Testing a new navigation system for heart ablation
Part of Heart & circulation clinical trials.
This trial offers a new imaging and guidance system called VERAFEYE during catheter ablation for people with paroxysmal atrial fibrillation (a type of irregular heartbeat). It aims to see if the system helps make the procedure safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can legally consent to the study in your state or country.
- You have paroxysmal (intermittent) atrial fibrillation and are scheduled for a catheter ablation procedure.
- Your doctor has decided the VERAFEYE system is a good option for your ablation.
- You understand what the study involves and are willing to give written consent.
- You can and will complete all required study check-ups and evaluations.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new imaging and guidance system, VERAFEYE, can help doctors perform catheter ablation for atrial fibrillation. It is designed for people with paroxysmal or persistent AF who are already scheduled for this procedure.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This registry tracks how well the VERAFEYE system works for people having a procedure to treat atrial fibrillation (a type of irregular heartbeat) or to close the left atrial appendage. It helps doctors see if using this imaging tool during the procedure is safe and effective.
This study tests a new imaging catheter (VERAFEYE) to help doctors guide ablation procedures for atrial flutter or atrial fibrillation. It may lead to safer, more precise treatment of these heart rhythm problems.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.